Media
Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
Click here to download our most recent fact sheet.
|
|
 = Add Release to Briefcase |
| All Releases |
|---|
 |
Corgentech to Webcast Presentation From 2006 Citigroup Global Health Care Conference
Feb 24, 2006
|
65.9 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 24, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John P. McLaughlin, the company's chief executive officer, will present at the 2006 Citigroup Global Health Care Conference on February 28, 2006 at 9:10 a.m. EST in Washington DC....
|
|
|
Corgentech Announces Fourth Quarter and Year-End 2005 Financial Results
Feb 23, 2006
|
83.5 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 23, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Corgentech Inc. (Nasdaq: CGTK) today reported financial results for the fourth quarter and year ended December 31, 2005.
"In 2005, we successfully revitalized the company by advancing our portfolio of four novel drug candidates for pain and inflammation...
|
|
|
Corgentech's Pivotal Phase 3 Trial of ALGRX 3268 Demonstrates Significant Pain Relief in Children Versus Placebo
Feb 21, 2006
|
75.3 KB
|
| |
SOUTH SAN FRANCISCO, Calif. and FORT MYERS, Fla., Feb 21, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Corgentech Inc. (Nasdaq: CGTK) today announced that researchers presented pivotal Phase 3 trial results from the second of two Phase 3 trials demonstrating that children undergoing medical procedures requiring venipunctures and intraven...
|
|
|
Corgentech to Announce Fourth Quarter and Year-End 2005 Financial Results and Host Webcast Conference Call on February 23, 2006
Feb 17, 2006
|
67.3 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 17, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, will announce financial results for the fourth quarter and year-end 2005 after the markets close on Thursday, February 23, 2006 and will hold a webcast teleconference at 4:30 p.m. EST that day. Member...
|
|
|
Corgentech Completes Patient Enrollment in Three Phase 2 Clinical Trials of Post-Surgical Pain Drug Candidate
Feb 9, 2006
|
71.6 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 09, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Corgentech Inc. (Nasdaq: CGTK) today announced that it has completed patient enrollment in three Phase 2 clinical trials of ALGRX 4975-one of three mid- to late-stage non-opioid pain management drug candidates the company is developing-to evaluate this nove...
|
|
|
